Dr. Toni De Marcaida, Medical Director of Hartford Healthcare’s Chase Family Movement Disorders Center in Hartford, CT, spoke this week on WFSB Channel 3 News about the positive impact the Syn-One Test has had on her practice and patients. “This is a test that has never been available to us as clinicians before.”
Todd Levine, MD, Chief Medical Officer and Co-Founder of CND Life Sciences was interviewed last month about the Syn-One Test® in a three-part series on the Lewy Body Roller Coaster podcast.
“It wasn’t until Robin’s autopsy that we got an accurate diagnosis,” explains Susan Schneider Williams, widow of the late comedian, in a talk she gave at Life Itself—a health and wellness conference presented in partnership with CNN.
Dr. Christopher H. Gibbons, Senior Scientific Advisor of CND Life Sciences, was recently interviewed in a Medscape Neurology story titled “Skin Testing May Help Detect Movement Disorders.”
Dr. Todd Levine, Chief Medical Officer and Co-Founder of CND Life Sciences will present as part of a Controversies in Movement Disorders panel discussion at 6:30 pm on May 23, 2022, in Punta Gorda, FL.
In honor of national Parkinson’s month, CN2 news in Rock Hill, SC featured Memory & Movement Charlotte, a medical practice focused on Parkinson’s disease and other neurological conditions, where Medical Director Dr. Sanjay Iyer has recently started offering the Syn-One Test to his patients.
Specialized neurologic and neurosurgical care center Marcus Neuroscience Institute, part of Baptist Health South Florida, is now offering its patients the Syn-One Test. Sameea Husain Wilson, D.O., director of Movement Disorder Neurology for the institute, cites the simplicity of administering the test, its high level of accuracy, and the speed with which patients get results as the major benefits of the test.
Aducanumab, the first treatment for Alzheimer’s disease to be approved in nearly two decades, has generated a fair share of interest—and controversy—since it was given approval by the FDA on June 7
Dr. Todd Levine, Co-Founder and Chief Medical Officer of CND Life Sciences made his podcast debut last week when he sat down with Sheryl Lowenhar, founder of 17 Branches, to talk about the Syn-One Test.
Dr. Timothy Prestley, Founder & Director of Novus Neurology & TMS in Tuscaloosa, Alabama, was interviewed this week live on ABC’s Talk of Alabama morning show.